Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Knapp

Showing results (51-60 of 540) with videos related to

Pageof 54
Sort By:
Nature Chemical Biology|October 21, 2015
The ins and outs of selective kinase inhibitor developmentSusanne Müller, Apirat Chaikuad, Nathanael S Gray, et al.
Journal of Medicinal Chemistry|July 14, 2012
Druggability analysis and structural classification of bromodomain acetyl-lysine binding sitesLewis R Vidler, Nathan Brown, Stefan Knapp, et al.
Bioorganic & Medicinal Chemistry|April 15, 2024
Expanding the ligand spaces for E3 ligases for the design of protein degradersRahman Shah Zaib Saleem, Martin P Schwalm, Stefan Knapp
Open Biology|May 30, 2023
Structural insights into a regulatory mechanism of FIR RRM1-FUSE interactionXiaomin Ni, Andreas C Joerger, Apirat Chaikuad, et al.
Chemical Society Reviews|August 25, 2022
PROTAC degraders as chemical probes for studying target biology and target validationVáclav Němec, Martin P Schwalm, Susanne Müller, et al.
Oncogene|May 4, 2021
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapyMarek Wanior, Andreas Krämer, Stefan Knapp, et al.
ACS Nano|December 28, 2018
Single-Molecule Protein Phosphorylation and Dephosphorylation by Nanopore EnzymologyLeon Harrington, Leila T Alexander, Stefan Knapp, et al.
Analytical and Bioanalytical Chemistry|August 25, 2012
Fragment screening of cyclin G-associated kinase by weak affinity chromatographyElinor Meiby, Stefan Knapp, Jonathan M Elkins, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 8, 2024
Thermodynamic Characterization of LC3/GABARAP:Ligand Interactions by Isothermal Titration CalorimetryJohannes Dopfer, Martin P Schwalm, Stefan Knapp, et al.
Methods in Enzymology|May 7, 2022
Enabling pseudokinases as potential drug targetsFranziska Preuss, Deep Chatterjee, Verena Dederer, et al.
Pageof 54

Showing results (51-60 of 540) with videos related to

Sort By:
Pageof 54
Nature Chemical Biology|October 21, 2015
The ins and outs of selective kinase inhibitor developmentSusanne Müller, Apirat Chaikuad, Nathanael S Gray, et al.
Journal of Medicinal Chemistry|July 14, 2012
Druggability analysis and structural classification of bromodomain acetyl-lysine binding sitesLewis R Vidler, Nathan Brown, Stefan Knapp, et al.
Bioorganic & Medicinal Chemistry|April 15, 2024
Expanding the ligand spaces for E3 ligases for the design of protein degradersRahman Shah Zaib Saleem, Martin P Schwalm, Stefan Knapp
Open Biology|May 30, 2023
Structural insights into a regulatory mechanism of FIR RRM1-FUSE interactionXiaomin Ni, Andreas C Joerger, Apirat Chaikuad, et al.
Chemical Society Reviews|August 25, 2022
PROTAC degraders as chemical probes for studying target biology and target validationVáclav Němec, Martin P Schwalm, Susanne Müller, et al.
Oncogene|May 4, 2021
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapyMarek Wanior, Andreas Krämer, Stefan Knapp, et al.
ACS Nano|December 28, 2018
Single-Molecule Protein Phosphorylation and Dephosphorylation by Nanopore EnzymologyLeon Harrington, Leila T Alexander, Stefan Knapp, et al.
Analytical and Bioanalytical Chemistry|August 25, 2012
Fragment screening of cyclin G-associated kinase by weak affinity chromatographyElinor Meiby, Stefan Knapp, Jonathan M Elkins, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 8, 2024
Thermodynamic Characterization of LC3/GABARAP:Ligand Interactions by Isothermal Titration CalorimetryJohannes Dopfer, Martin P Schwalm, Stefan Knapp, et al.
Methods in Enzymology|May 7, 2022
Enabling pseudokinases as potential drug targetsFranziska Preuss, Deep Chatterjee, Verena Dederer, et al.
Pageof 54